Algocyte® is OIA’s flagship brand for a suite of generative Artificial General Intelligence-driven offerings that enable a full end-to-end individualised solution for precision health and predictive medicine.
Algocyte® assesses individual risk based on what it has learned from the user over time and uses guardrailed Generative AI to create prompts for humans to help clinicians in the process of diagnosis discovery and hypothesis testing.
This innovative feature helps triage users and can flag deviations from the user's own personal baseline while meaningfully quantifying change, allowing a level of personalisation and sophistication not available before based on the analysis of clinical biomarkers, cross-referenced with lifestyle and clinical events reported by the user or their health professionals.
Algocyte® learns people’s optimal health over time
Platform v.1.0 In compliance with European Commission Directive 98/79/EC for General IVD device and UK Medical Devices Regulations 2002 and for general IVD device.
Source-agnostic: User medical data from multiple sources: printouts (OCR), lab (HL7), and other compatible devices (both from clinicians and patients enriched with lifestyle data for clinician-oriented hypothesis generation
Data merging aggregator
Designed by their health professionals supported by guardrailed Generative AI to capture adverse events from patients at testing time or any other time and aligned with medical guidance and healthcare pathways
Dynamic questionnaires
Learns from the user’s health behaviour over time and builds a profile and personal baselines. Generative guardrailed AI is used for diagnosis discovery and differential diagnostic support by creating prompts aligned with medical guidance
Precision health
Delivers on the promise of early detection and personalised medicine by harnessing currently available and most popular medical tests, making them accessible for regular and remote monitoring
Flags for rapid changes
Tested against a sample of hundreds of thousands of real clinical cases. It separates healthy from non-healthy cases using regular blood test markers (even in the presence of significant noise)
User & patient triaging
Compliant with medical regulations and data privacy and governance guidelines including GDPR and NHS DSP
Private & Secure
Algocyte® enables highly scalable & universal software-style Health-as-a-Service solution.
Design Application U.S. No. 29/855,827, UK 6201272 & 6201273, 008931349-0003 & 008931349-0004Coined by OIA’s founder, causal diagnostics is a cutting-edge and responsible, model-based approach to medicine different from simplistic AI-powered approaches that are based on traditional statistical methods ill-equipped to deal with multifactorial complexity.
Two-way meaningful communication capabilities between user and health professional to match symptoms and adverse effects to medical results thereby enriching and cross-referencing lab tests with physiological data and subjective feeling.
OIA are pioneers in Artificial General Intelligence applied to complex cell and biological data. AGI is a type of AI that mimics human reasoning enabled by a combination of cutting-edge symbolic and neural computation that relies on both human mind-type processes and machine intelligence.
Significantly less invasive, at-home, regular, precise, and cost-effective health monitoring enabled by portability, simplicity, and affordability contributes to democratising healthcare and eventually standard of care to everyone.
One-step protocol test with proprietary rapid-stain reagent and patented microfluidics device
U.S. Patents 11175230 and 11534751,
The future of health care
Algocyte® applies algorithms for personalised medicine to monitor the immune system and blood-related conditions based on blood testing.
Algocyte-compatible device
AGI enables low-cost instruments for a fully scalable Health-as-a-Service model.
Agnostic platform with universal integration
Capable of transferring files through and from our cloud APIs, LIMS and EPRs
Assay integration by helping design the cartridge and software plug-in to implement any test
Two-way communication that helps with drug adherence and creates a better clinician-patient relationship
Device agnostic that capture’s multiple user’s health data and lifestyle from any source
Health-as-a-Service model that creates loyalty based on value
Directs clinically-driven questionnaires to users to collect and cross-reference multiple data
Can learn and build each person’s personal health database
First commercial multi-omics patient-oriented platform
Advanced predictive capabilities (award-winning engine able to predict the continuation of time series and complex medical models)
Agnostic AGI platform
A more efficient and timelier, medically-driven, supportive remote patient monitoring system
A visual dashboard and individualised smart report for patients
Analysis of trends based on proven scores and patient’s personalised baselines
A reduction in hospital/clinic visits and infection risks, keeping patients at their homes
Helps find the optimal balance in treatment cycles between efficacy and tolerance
Enables clinicians to deliver regular contact and care to patients
Relieves clinicians of time-consuming tasks. In an independent survey conducted by the NHS, doctors, and nurses said they could save up to 2-3 hours a week each by using Algocyte’s automation tools
Health bottlenecks that Algocyte® can help unblock and optimise
Oncology patients require frequent blood monitoring required during treatment. This is highly disruptive for the patient and their families, particularly for children.
Some patients can now have their treatment taken at home such as oral chemo but still have to travel to get their blood tests done.
Adding to their stress, patients do not know if their symptoms are the result of the therapy affecting their immune system or a serious infection to take care of immediately.
When traveling to labs or hospitals, they put themselves at risk of infection with weak immune systems from hospital-acquired infections that can account for more than 10% of all infections and can be lethal for cancer patients.
Health professionals also struggle to have timely and precise health information to schedule the next individualised therapy cycle as they have to wait for scheduling appointments and for the results.
Oncology
Community health workers around the world, both in developing and developed countries, are key agents that assist in decreasing the global burden of disease and treatment in the communities they serve.
They help collect and store blood samples that they bring to labs to run the required tests but they are bounded by distance and time to do more.
On the one hand, one of the challenges of community health workers is to find the fine balance between maximising coverage and minimising haemolysis as a result of storing and transporting these samples.
On the other hand, health professionals often have to wait for hours or days to get access to the patient’s results after samples are taken to the lab which make it a suboptimal process and a health bottleneck.
Community nursing
For those individuals living in retirement and nursing homes, regular personalised health monitoring and blood sampling are important components of their everyday lives and their continued health and longevity.
Their health allies can help them monitor themselves while keeping their health professionals, and even their families, updated in real-time on a regular basis even from remote locations.
The Algocyte solution can be delivered where and when they need it, without leaving the comfort and safety of the facility. This while learning from and building their optimal health profile from personalised and precise access to their health allowing them to get back to enjoying themselves and preserving, as much as possible, their way of life.
Retirement & nursing homes
Health & wellness awareness
Health and wellness awareness dates back centuries and is very relevant today because people empowered by science and technology are able to make personal decisions, intervene, and make a difference.
We are entering a new era of health consumers with unprecedented access to health information and a diversity of choices available to live longer and healthier.
Clinical literature now supports more frequent blood monitoring, even in otherwise healthy individuals to understand health before disease.
What if there was a better way for all these users, patients, and their families to solve most of these health and disease-related challenges?
The solution is Algocyte®.
Want to find out more?
In our downloadable PDF, we share the in-depth science behind our breakthrough product. Delve into the specifics of our leading immune system monitoring platform.